Rehovot-based developer of diagnostic tools for ADHD condition in order to help professionals improve their patient’s everyday functioning, well-being, and academic performance and achievement. Enables clinicians to better diagnose and evaluate the on-going treatment in order to monitor its efficiency. Offers real-time assessment of the patient’s condition narrowed down to cognitive core elements as Hyperactivity, Impulsiveness, and Attention Deficit with diagnostic accuracy of 95% compared to less than 70% with the current market leaders. Research validation was conducted at Hadassah Hospital, and the validity was recognized by Leumit & Maccabi HMOs. Seeking assistance in entering the US market and introductions to clinics.